Long-term unsupervised mobility assessment in movement disorders
نویسندگان
چکیده
منابع مشابه
Movement disorders secondary to long-term treatment with cyclosporine A.
OBJECTIVE To analyze the prevalence, severity and functional interference of movement disorders (MD) secondary to chronic use of cyclosporine A (CsA). METHOD We conducted a cross-sectional study of 60 patients (58.3% male) with mean age 23.1 (3-75) years, followed at the Bone Marrow Transplantation Service of the Hospital de Clínicas of the Federal University of Paraná, Brazil, taking CsA for...
متن کاملLong-term prognosis of patients with psychogenic movement disorders.
Psychogenic movement disorders (PMD) are hyper- or hypokinetic movement disorders associated with underlying psychological or psychiatric disorders. Structured telephone interview was administered to 228 patients with PMD seen in our clinic between 1990 and 2003. The mean age of the subjects was 42.3+/-14.3 years (range 14-70 years), mean duration of symptoms was 4.7+/-8.1 years (range 2-14 yea...
متن کاملUnsupervised online learning for long-term autonomy
A reliable representation of the environment a robot operates in is vital for solving complex tasks. Models that represent information about objects and their properties are typically trained beforehand using supervised methods. This requires intensive human labeling which makes it time-consuming and results in models that are generally inflexible to changes. We would prefer a robot that can bu...
متن کاملLong-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
We sought to review the long-term tolerability of tetrabenazine (TBZ) and seek determinants of tolerability in the treatment of hyperkinetic movement disorders. A retrospective chart review was performed on patients treated with TBZ between 1997 and 2004. Efficacy of TBZ was assessed by a 1- to 5-point response scale (1 = marked reduction in abnormal movements, 5 = worsening). All adverse event...
متن کاملEffect of Long-Term Captopril Administration on Bone Density and Orthodontic Tooth Movement
Background and Aim: Captopril is an oral angiotensin-converting-enzyme (ACE) inhibitor extensively used in the treatment of hypertension and heart failure. ACE has been suggested to function in bone cells and might therefore impact orthodontic tooth movement (OTM). Considering the controversy surrounding the effects of ACE and its inhibitors on osseous tissues, we aimed to evaluate the effect o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet Neurology
سال: 2020
ISSN: 1474-4422
DOI: 10.1016/s1474-4422(19)30397-7